Cargando…

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma

AIM: The purpose of the study was to evaluate the clinical impact of fluorodeoxyglucose‐positron emission tomography/computed tomography (FDG‐PET/CT) followed by a new biopsy from the site with maximum standardized uptake value (SUVmax) in case of high maximal SUV values, in detecting clinically uns...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajamäki, Aino, Kuitunen, Hanne, Sorigue, Marc, Kokkonen, Salla‐Maarit, Kuittinen, Outi, Sunela, Kaisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	BRIEF COMMUNICATION
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844644/ https://www.ncbi.nlm.nih.gov/pubmed/35661431 http://dx.doi.org/10.1002/cam4.4924

Ejemplares similares

Mortality among patients with low‐grade follicular lymphoma: A binational retrospective analysis
por: Rajamäki, Aino, et al.
Publicado: (2022)

Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
por: Harmanen, Minna, et al.
Publicado: (2023)

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions
por: Tokola, Susanna, et al.
Publicado: (2021)

Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas
por: Sorigue, Marc, et al.
Publicado: (2022)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
por: Tokola, Susanna, et al.
Publicado: (2020)

Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
por: Puhakka, Inka, et al.
Publicado: (2022)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
por: Kuitunen, Hanne, et al.
Publicado: (2020)

Shear wave elastography as a supplemental tool in the assessment of unsuspicious axillary lymph nodes in patients undergoing breast ultrasound examination
por: Togawa, Riku, et al.
Publicado: (2022)

Rebiopsy rate after transperineal or transrectal prostate biopsy
por: Marenco Jimenez, Jose L., et al.
Publicado: (2021)

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma
por: Partanen, Anu, et al.
Publicado: (2021)

FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management
por: Gallamini, Andrea, et al.
Publicado: (2017)

The characteristics and spatial distributions of initially missed and rebiopsy-detected prostate cancers
por: You, Myung-Won, et al.
Publicado: (2016)

Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
por: Ahn, Hyein, et al.
Publicado: (2018)

Vitamin C boosts DNA demethylation in TET2 germline mutation carriers
por: Taira, Aurora, et al.
Publicado: (2023)

Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events
por: Jokimäki, Anna, et al.
Publicado: (2023)

Biopsy and rebiopsy for non-small-cell lung cancer: current and future methods
por: Zarogoulidis, Paul, et al.
Publicado: (2019)

Rebiopsy with Thoracoscopy under Local Anesthesia for the Detection of EGFR T790M Mutation
por: Matsuda, Asako, et al.
Publicado: (2019)

Significance of initial, interim and end-of-therapy (18)F-FDG PET/CT for predicting transformation risk in follicular lymphoma
por: Xie, Mixue, et al.
Publicado: (2021)

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review
por: Adams, Hugo J. A., et al.
Publicado: (2015)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments
por: Jekunen, Antti P.
Publicado: (2015)

Supporting Remote Social Robot Design Collaboration with Online Canvases: Lessons Learned from Facilitators’ and Participants’ Experiences
por: Ahtinen, Aino, et al.
Publicado: (2023)

A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms
por: Pathak, K. Alok, et al.
Publicado: (2016)

Follicular lymphoma with hepatic accumulation on FDG-PET/CT masquerading IgG4-related disease
por: Ishizuka, Kosuke, et al.
Publicado: (2021)

Radiotherapy in Follicular Lymphoma Staged by (18)F-FDG-PET/CT: A German Monocenter Study
por: Karsten, Imke E., et al.
Publicado: (2021)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
por: So, Heejune, et al.
Publicado: (2023)

Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
por: Tseng, Jeng-Sen, et al.
Publicado: (2018)

Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer
por: Fukui, Tomoya, et al.
Publicado: (2019)

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC
por: Koyama, Kenichi, et al.
Publicado: (2022)

Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies
por: Christopoulos, Petros, et al.
Publicado: (2021)

CD34(+) Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients
por: Turunen, Antti Samuli, et al.
Publicado: (2023)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

FDG-PET/CT Provides Clues on Bone Marrow Involvement in Follicular Lymphoma and Carries Important Prognostic Information
por: Jing, Yaoyao, et al.
Publicado: (2023)

Transrectal ultrasound-guided prostate rebiopsy: How many core sampling should be applied to which patient?
por: Amasyalı, Akın Soner, et al.
Publicado: (2018)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases
por: Häyrinen, Marjaana J., et al.
Publicado: (2023)

Metachronous presentation of small-cell rectal carcinoma on an 18F-FDG PET/CT follow-up for follicular lymphoma
por: Qaseem, Yousuf, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v1v1pctio1ahoaovaqef07mgdv